scispace - formally typeset
Open AccessJournal ArticleDOI

Esophageal carcinoma advances in treatment results for locally advanced disease: review

TLDR
Chemo (PF) before surgery improved overall survival (OS) in those patients in most of the randomized trials and in meta-analyses and it was found that those patients with pathologic complete response to the initial treatment did better than those who had no improvement at all.
About
This article is published in Annals of Oncology.The article was published on 2012-05-01 and is currently open access. It has received 96 citations till now. The article focuses on the topics: Chemoradiotherapy & Combined Modality Therapy.

read more

Citations
More filters
Journal ArticleDOI

Towards predicting the response of a solid tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational model.

TL;DR: A hybrid multiscale mathematical model is used that incorporates both individual cell behaviour through the cell-cycle and the effects of the changing microenvironment through oxygen dynamics to study the multiple effects of radiation therapy.
Journal ArticleDOI

MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma

TL;DR: The data suggest that MMP1 functions as an oncogene and serves as a prognostic biomarker and a potential therapeutic target in ESCC.
Journal ArticleDOI

Outcome of patients with esophageal cancer: a nationwide analysis.

TL;DR: The data indicated that age, sex, and curative treatment were significant predictors of lifetime survival in patients with esophageal cancer, andCurative treatment with surgery improved the survival of esophagal cancer patients more significantly compared with patients who undergo definite radiotherapy.
References
More filters
Journal ArticleDOI

Global cancer statistics

TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal ArticleDOI

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

TL;DR: In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival.
Journal ArticleDOI

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

TL;DR: The authors update the incidence trends through 1994 and further consider the trends by age group.
Journal ArticleDOI

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

TL;DR: Multimodal treatment is superior to surgery alone for patients with resectable adenocarcinoma of the esophagus, with the survival advantage favoring multimodal therapy reaching significance at three years.
Journal ArticleDOI

Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus

TL;DR: In this article, a phase III prospective, randomized, and stratified trial was undertaken to evaluate the efficacy of four courses of combined fluorouracil (1000 mg per square meter of body-surface area daily for four days) and cisplatin (75 mg persquare meter on the first day) plus 5000 cGy of radiation therapy, as compared with 6400 cGyof radiation therapy alone, in patients with squamous-cell carcinoma or adenocarcinoma of the thoracic esophagus.
Related Papers (5)